Mirum Pharmaceuticals Inc (MIRM)
43.48
-0.21
(-0.48%)
USD |
NASDAQ |
Nov 21, 16:00
43.48
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Total Liabilities (Quarterly): 435.87M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 435.87M |
| June 30, 2024 | 431.77M |
| March 31, 2024 | 417.36M |
| December 31, 2023 | 397.95M |
| September 30, 2023 | 381.56M |
| June 30, 2023 | 364.98M |
| March 31, 2023 | 192.38M |
| December 31, 2022 | 210.87M |
| September 30, 2022 | 195.05M |
| June 30, 2022 | 186.55M |
| March 31, 2022 | 169.22M |
| December 31, 2021 | 174.44M |
| Date | Value |
|---|---|
| September 30, 2021 | 178.77M |
| June 30, 2021 | 151.93M |
| March 31, 2021 | 88.36M |
| December 31, 2020 | 68.77M |
| September 30, 2020 | 21.61M |
| June 30, 2020 | 19.56M |
| March 31, 2020 | 16.68M |
| December 31, 2019 | 16.36M |
| September 30, 2019 | 12.07M |
| June 30, 2019 | 132.22M |
| March 31, 2019 | 67.56M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
16.36M
Minimum
Dec 2019
435.87M
Maximum
Sep 2024
206.00M
Average
182.66M
Median
Total Liabilities (Quarterly) Benchmarks
| Arcutis Biotherapeutics Inc | 280.71M |
| Cytokinetics Inc | 1.450B |
| Amicus Therapeutics Inc | 607.73M |
| MannKind Corp | 674.13M |
| TG Therapeutics Inc | 393.86M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 667.89M |
| Shareholders Equity (Quarterly) | 232.02M |
| Debt to Equity Ratio | 1.326 |
| Current Ratio | 3.340 |
| Net Debt Paydown Yield | -0.02% |